Baricitinib for Refractory Takayasu Arteritis
Clinical trial NCT06662721 · COMPLETED
Trial details
- NCT number
- NCT06662721
- Sponsor
- Liu Tian
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2023-12-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.